Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients (Vol 13, 1280587, 2023)

被引：0

作者：

Mosleh, Ema ^{[1
]}

Snyder, Stacy ^{[1
,5
]}

Wu, Ningying ^{[2
,3
]}

Willis, Daniel N. ^{[1
]}

Malone, Rema ^{[4
]}

Hayashi, Robert J. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63130 USA

[2] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci,Biostat Shared Resource, St Louis, MO USA

[3] Washington Univ, Siteman Canc Ctr, Sch Med, Dept Surg, St Louis, MO USA

[4] St Louis Childrens Hosp, Div Pediat Hematol Oncol, St Louis, MO USA

[5] Beacon Hlth Syst, South Bend, IN USA

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

methotrexate; HDMTX; supportive care; delayed clearance; nephrotoxicity; adverse effect; pediatric cancer; AYA;

D O I：

10.3389/fonc.2023.1333273

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1